Vivaldi Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-5,489
Closed -$288K 353
2020
Q3
$288K Buy
+5,489
New +$227K 0.06% 198

Vivaldi Capital Management's MNTA Position: Q4 2020 in Review

Vivaldi Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 5,489 shares — an estimated $288K sold.

Vivaldi Capital Management first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $288K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Vivaldi Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Vivaldi Capital Management sold 5,489 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $288K.
  • Vivaldi Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Vivaldi Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $288K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Vivaldi Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.